Women's Hospital School Of Medicine Zhejiang University
Clinical trials sponsored by Women's Hospital School Of Medicine Zhejiang University, explained in plain language.
-
New Two-Pronged attack tested against tough cervical cancers
Disease control Not yet recruitingThis study is testing if adding a new immunotherapy drug, Ivonescimab, to standard chemotherapy before radiation treatment is safe and more effective for women with high-risk, locally advanced cervical cancer. The goal is to better control the cancer and prevent it from coming ba…
Phase: PHASE2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Drug combo aims to shrink tumors, spare women surgery
Disease control Not yet recruitingThis study is testing whether a combination of two immunotherapy drugs can shrink tumors enough to avoid surgery in women with a specific, surgically removable type of endometrial cancer. It will enroll about 30 women who have not had recent cancer treatment. The main goal is to …
Phase: PHASE2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC